Long non-coding RNAs (lncRNA) as treatment efficacy markers in patients with advanced melanoma harboring BRAF mutation.
2016/21/B/NZ7/01773
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ5_7: Leczenie chorób człowieka
- NZ7_16: Inne zagadnienia pokrewne
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Nauk o Zdrowiu
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
OPUS 11 – announced on 2016-03-15
- Amount awarded
- 804 972 PLN
- Project start date
- 2017-01-18
- Project end date
- 2021-09-17
- Project duration
- 56 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komora do PCR.
- Komputer wraz z systemem operacyjnym (2 pcs). Cost: 16 000 PLN
- Stacja robocza Dell Precision. Cost: 24 464 PLN
- Termocykler do reakcji PCR w czasie rzeczywistym. Cost: 120 000 PLN
- Wirówka laboratoryjna. Cost: 20 000 PLN
- Zamrażarka niskotemperaturowa wraz z czujnikiem.
- Zestaw pipet laboratoryjnych (2 pcs). Cost: 14 000 PLN
Information in the final report
Publication in academic press/journals (1)
-
Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor
- Authors:
- Tomasz Kolenda, Piotr Rutkowski , Michał Michalak , Katarzyna Kozak , Kacper Guglas , Marcel Ryś , Łukasz Galus , Sebastian Woźniak , Iwona Ługowska , Aleksadndra Gos , Anna Teresiak , Andrzej Mackiewicz , Katarzyna Lamperska , Jacek Mackiewicz
- Academic press:
- Oncotarget (year: 2019, volume: 10, pages: 3879-3893), Publisher: Impact Journals, LLC
- Status:
- Published
- DOI:
- 10.18632/oncotarget.26989 – link to the publication